Merit Medical Systems, Inc. adds the Ostial Pro® Stent Positioning System, designed to help accurately place stents.

Merit Medical continues to invest in bringing value-rich tools to the hands of skilled physicians. The next product to be added to Merit’s cardiology portfolio is the Ostial Pro® Stent Positioning System, launching in Q1 2012. This device was recently acquired from Ostial Solutions, LLC.

The Ostial Pro® is a Nitinol device with gold-plated feet to ensure accurate placement of stents at the junction of arterial vessels with the aorta. It is estimated that between 2% and 15% of coronary stent placements are ostial1. Missing distal or proximal to the target lesion can result in a number of complications and added costs. This device provides a simple and efficient means for accurate aorto-ostial stent placement and minimal residual stenosis in difficult-to-treat lesions.

Current studies show that the use of the Ostial Pro® is associated with decreased procedure times, radiation exposure, and a lower volume of radiographic contrast use, which reduces costs for both the hospital and the health care system2.

Stay tuned for additional information on this innovative product.


1 Fischell, TA. Initial clinical experience using an ostial stent positioning system (Ostial Pro™) for the accurate placement of stents in the treatment of coronary aorto-ostial lesions. J Invasive Cardiol. 2009 Feb; 21(2):53-59.

2 Kwan, TW. What is the price for perfection for precise aorto-ostial placement? J Invasive Cardiol. 2011 Aug; 23(8): 327.

Merit Reaches Distribution Agreement for the Clo-SurPLUS P.A.D.™

Merit Medical Systems, Inc. has negotiated a long-term distribution agreement with Scion Cardio-Vascular to sell its Clo-SurPLUS P.A.D., a soft, non-woven topical pad that provides an optimal wound-healing environment with an effective antibacterial barrier. The pad is intended for the local management of bleeding wounds and to provide a barrier to bacterial penetration of the dressing. For Interventional Cardiologists and Radiologists with patients who are anti-coagulated or who have bleeding complications after interventional or diagnostic peripheral vascular procedures, the Clo-SurPLUS P.A.D. can effectively coagulate fully heparinized blood. The Clo-SurPLUS P.A.D. reduces hold time as well as time to ambulation.

The pad is versatile and can be placed around sites involving percutaneous catheters, tubes, and pins. The Clo-SurPLUS P.A.D. has demonstrated in-vitro antibacterial activity for up to 6 days. It is water soluble for easy and painless removal, which is more comfortable for the patient.

Mark Heninger
Sr. Product Manager
Merit Medical Systems, Inc.